Cleared Traditional

RxG Distraction System

K150771 · KLS-Martin L.P. · Neurology
Aug 2015
Decision
156d
Days
Class 2
Risk

About This 510(k) Submission

K150771 is an FDA 510(k) clearance for the RxG Distraction System, a Cranial Distraction System (Class II — Special Controls, product code PBJ), submitted by KLS-Martin L.P. (Jacksonville, US). The FDA issued a Cleared decision on August 27, 2015, 156 days after receiving the submission on March 24, 2015. This device falls under the Neurology review panel. Regulated under 21 CFR 882.5330.

Submission Details

510(k) Number K150771 FDA.gov
FDA Decision Cleared SESE
Date Received March 24, 2015
Decision Date August 27, 2015
Days to Decision 156 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code PBJ — Cranial Distraction System
Device Class Class II — Special Controls
CFR Regulation 21 CFR 882.5330
Definition A Cranial Distraction System Is A Metal Device Intended To Establish Osteodistraction And Bone Growth In The Skull. The Bone Segments Are Attached To The Plate With Screws To Prevent Movement Of The Segments.

More from KLS-Martin L.P.

View all
KLS Martin Pure Pectus System
K253660 · HRS · Feb 2026
KLS Martin Ixos System
K254162 · Feb 2026
KLS Martin Pure Pectus System
K250988 · HRS · Dec 2025
KLS Martin IPS Forearm System
K250865 · HRS · Nov 2025
KLS Martin Cranial Implants - MR Conditional; K944565: KLS-Martin Micro Osteosynthesis System (1.5MM); K971297: KLS Martin Centre-Drive Drill-Free Screw; K060177: KLS Martin Rigid Fixation - Sterile; K062570: Individual Patient Solutions - Ti (IPS-Ti); K072707: Individual Patient Solutions - PEEK (IPS-PEEK) ; K151382: Individual Patient Solutions - (IPS-PEEK) - STERILE
K252573 · GXN · Nov 2025